| Reduced Risk Status: |
|
| IPM Compatibility: |
PER REQUESTOR: GOOD IPM FIT; EFFECT ON BENEFICIALS IS LIMITED, AND DEFINITELY WORKS WELL IN THE GH PROGRAM:05/16
|
| Reasons for need: |
PSYLLIDS, PEPPER WEEVIL, THRIPS, LEPIDOPTERA
|
| Requesting State(s): |
CA:Ingersoll, T ; KY:Bessin, R ; ME:Gondoza, H ; NV:Ingersoll, T ; TX:Bledsoe, M ;
|
| PCR Use Pattern: |
USE THE XXPIRE WG PRODUCT; USE RADIENT AI/A RATES; MAKE 3-4 FOLIAR APPLIC, 10-14 DAY INTERVAL; 0-1 DAY PHI
|
| EPA Default Residue Trials: |
ANY 4 TRIALS
|
| IR-4 Residue Trial Plan: |
ANY 4 TRIALS (2 SMALL-FRUITED AND 2 LARGE-FRUITED TRIALS), 1 DECLINE TRIAL
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
PMC CANADA CONDUCTED 1 VALUE TRIAL IN 2017
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
PEND:06/21
QA:04/20
SP-PROP:01/23
SP-RULE:08/23
SP-RULE:09/23
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
CANADA IS A KEY EXPORT MARKET:05/16; MFG TO CONFIRM IF THERE IS DATA AVAILABLE THAT COULD COVER THIS USE:06/16; COVERS SOLO SPINETORAM REQUEST 09947:08/18; SPINETORAM WAS SUBMITTED TO EPA 03/22, SUFOXAFLOR IS ON HOLD 04/22, PLEASE SEE PR# 13440:04/22; NOTICES OF FILING (TOLORANCE PROPOSALS) PUBLISHED IN THE FED REG FOR SPINETORAM & "SPINOSAD":01/23/sb; Spinosad rec'd a permanent tolerance/rule published in the fed reg:08/23/sb; Spinetoram rec'd a permanent tolerance/rule published in the fed reg:09/23/sb
|
| International Status: |
|
| Archive Location: |
105-5; 002859, 003326(R)
|
| QA Archive: |
002818, 48-4
|